Aequus Pharmaceuticals' market value is the price at which a share of Aequus Pharmaceuticals trades on a public exchange. It measures the collective expectations of Aequus Pharmaceuticals investors about its performance. Aequus Pharmaceuticals is trading at 0.0067 as of the 18th of January 2025. This is a 4.29 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.0067. With this module, you can estimate the performance of a buy and hold strategy of Aequus Pharmaceuticals and determine expected loss or profit from investing in Aequus Pharmaceuticals over a given investment horizon. Check out Aequus Pharmaceuticals Correlation, Aequus Pharmaceuticals Volatility and Aequus Pharmaceuticals Alpha and Beta module to complement your research on Aequus Pharmaceuticals.
Please note, there is a significant difference between Aequus Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aequus Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aequus Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Aequus Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Aequus Pharmaceuticals' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Aequus Pharmaceuticals.
0.00
12/19/2024
No Change 0.00
0.0
In 31 days
01/18/2025
0.00
If you would invest 0.00 in Aequus Pharmaceuticals on December 19, 2024 and sell it all today you would earn a total of 0.00 from holding Aequus Pharmaceuticals or generate 0.0% return on investment in Aequus Pharmaceuticals over 30 days. Aequus Pharmaceuticals is related to or competes with Crescita Therapeutics. Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, develops and commercializes drugs in Canada More
Aequus Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Aequus Pharmaceuticals' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Aequus Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aequus Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Aequus Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Aequus Pharmaceuticals historical prices to predict the future Aequus Pharmaceuticals' volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Aequus Pharmaceuticals. Your research has to be compared to or analyzed against Aequus Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Aequus Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Aequus Pharmaceuticals.
Aequus Pharmaceuticals Backtested Returns
Aequus Pharmaceuticals appears to be out of control, given 3 months investment horizon. Aequus Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0196, which signifies that the company had a 0.0196% return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Aequus Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please makes use of Aequus Pharmaceuticals' Mean Deviation of 4.6, risk adjusted performance of 0.0255, and Downside Deviation of 20.63 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Aequus Pharmaceuticals holds a performance score of 1. The firm shows a Beta (market volatility) of 1.83, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Aequus Pharmaceuticals will likely underperform. Please check Aequus Pharmaceuticals' maximum drawdown, as well as the relationship between the expected short fall and day median price , to make a quick decision on whether Aequus Pharmaceuticals' price patterns will revert.
Auto-correlation
0.12
Insignificant predictability
Aequus Pharmaceuticals has insignificant predictability. Overlapping area represents the amount of predictability between Aequus Pharmaceuticals time series from 19th of December 2024 to 3rd of January 2025 and 3rd of January 2025 to 18th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Aequus Pharmaceuticals price movement. The serial correlation of 0.12 indicates that less than 12.0% of current Aequus Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient
0.12
Spearman Rank Test
0.29
Residual Average
0.0
Price Variance
0.0
Aequus Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Aequus Pharmaceuticals otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Aequus Pharmaceuticals' otc stock expected returns. We can calculate the autocorrelation of Aequus Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Aequus Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Aequus Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Aequus Pharmaceuticals otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Aequus Pharmaceuticals otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Aequus Pharmaceuticals otc stock over time.
Current vs Lagged Prices
Timeline
Aequus Pharmaceuticals Lagged Returns
When evaluating Aequus Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Aequus Pharmaceuticals otc stock have on its future price. Aequus Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Aequus Pharmaceuticals autocorrelation shows the relationship between Aequus Pharmaceuticals otc stock current value and its past values and can show if there is a momentum factor associated with investing in Aequus Pharmaceuticals.
Other Information on Investing in Aequus OTC Stock
Aequus Pharmaceuticals financial ratios help investors to determine whether Aequus OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aequus with respect to the benefits of owning Aequus Pharmaceuticals security.